MPH HEALTH CARE AG KONV (93M1.DE) Stock Price, Forecast & Analysis
Europe - Frankfurt Stock Exchange - FRA:93M1 - DE000A289V03 - Common Stock
93M1.DE Key Statistics, Chart & Performance
The current stock price of 93M1.DE is 18.05 EUR. In the past year, price decreased by -26.02%.
93M1.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 1SAN.MI | SANOFI | 11.54 | 213.66B | ||
| SAN.PA | SANOFI | 11.31 | 209.37B | ||
| SNW.DE | SANOFI | 11.35 | 209.50B | ||
| MRK.DE | MERCK KGAA | 13.22 | 49.04B | ||
| UCB.BR | UCB SA | 36.78 | 45.92B | ||
| UNC.DE | UCB SA | 34.83 | 43.49B | ||
| BAYN.DE | BAYER AG-REG | 5.73 | 30.06B | ||
| 1BAYN.MI | BAYER AG-REG | 5.15 | 27.01B | ||
| IPN.PA | IPSEN | 12.42 | 10.69B | ||
| REC.MI | RECORDATI INDUSTRIA CHIMICA | 25.43 | 10.48B | ||
| 1JAZZ.MI | JAZZ PHARMACEUTICALS PLC | 21.74 | 9.34B | ||
| TUB.BR | FINANCIERE DE TUBIZE | 98.32 | 9.10B |
Related stock screener links
About 93M1.DE
Company Profile
MPH Health Care AG is an investment company, which engages in the acquisition and development of companies and shares in companies from the healthcare industry. The company is headquartered in Berlin, Berlin and currently employs 2 full-time employees. The company went IPO on 2009-01-01. The firm focuses on the purchase, development and sale of companies and shares in companies from the healthcare market. The firm's portfolio comprises HAEMATO AG, M1 Kliniken AG and MPH Ventures. HAEMATO AG is a pharmaceutical company that offers generics for the therapies of cancer, human immunodeficiency virus (HIV) and other chronic diseases. M1 Kliniken AG focuses on the medicinal beauty market and develops and sells pharmaceutical and medical products and services, as well as medical devices for the aesthetic surgery and cosmetic dermatology. MPH Ventures operates as venture capitalist and invests in Pharmigon GmbH, a company specialized in cytostatic admixture and concomitant medications, as well as in the real estate company CR Capital Real Estate AG.
Company Info
MPH HEALTH CARE AG KONV
Gruenauer Strasse 5
Berlin BERLIN DE
Employees: 2
Phone: 4930863214560
MPH HEALTH CARE AG KONV / 93M1.DE FAQ
Can you describe the business of MPH HEALTH CARE AG KONV?
MPH Health Care AG is an investment company, which engages in the acquisition and development of companies and shares in companies from the healthcare industry. The company is headquartered in Berlin, Berlin and currently employs 2 full-time employees. The company went IPO on 2009-01-01. The firm focuses on the purchase, development and sale of companies and shares in companies from the healthcare market. The firm's portfolio comprises HAEMATO AG, M1 Kliniken AG and MPH Ventures. HAEMATO AG is a pharmaceutical company that offers generics for the therapies of cancer, human immunodeficiency virus (HIV) and other chronic diseases. M1 Kliniken AG focuses on the medicinal beauty market and develops and sells pharmaceutical and medical products and services, as well as medical devices for the aesthetic surgery and cosmetic dermatology. MPH Ventures operates as venture capitalist and invests in Pharmigon GmbH, a company specialized in cytostatic admixture and concomitant medications, as well as in the real estate company CR Capital Real Estate AG.
What is the stock price of MPH HEALTH CARE AG KONV today?
The current stock price of 93M1.DE is 18.05 EUR. The price increased by 0.84% in the last trading session.
What is the dividend status of MPH HEALTH CARE AG KONV?
MPH HEALTH CARE AG KONV (93M1.DE) has a dividend yield of 6.7%. The yearly dividend amount is currently 0.
What is the ChartMill technical and fundamental rating of 93M1 stock?
93M1.DE has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Who owns MPH HEALTH CARE AG KONV?
You can find the ownership structure of MPH HEALTH CARE AG KONV (93M1.DE) on the Ownership tab.
93M1.DE Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to 93M1.DE. When comparing the yearly performance of all stocks, 93M1.DE is a bad performer in the overall market: 85.03% of all stocks are doing better.
93M1.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to 93M1.DE. While 93M1.DE seems to be doing ok healthwise, there are quite some concerns on its profitability.
93M1.DE Financial Highlights
Over the last trailing twelve months 93M1.DE reported a non-GAAP Earnings per Share(EPS) of -26.91. The EPS decreased by -196.45% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -52.66% | ||
| ROE | -56.18% | ||
| Debt/Equity | 0.02 |